1. Home
  2. LEGN vs FRT Comparison

LEGN vs FRT Comparison

Compare LEGN & FRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • FRT
  • Stock Information
  • Founded
  • LEGN 2014
  • FRT 1962
  • Country
  • LEGN United States
  • FRT United States
  • Employees
  • LEGN N/A
  • FRT N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • FRT Real Estate Investment Trusts
  • Sector
  • LEGN Health Care
  • FRT Real Estate
  • Exchange
  • LEGN Nasdaq
  • FRT Nasdaq
  • Market Cap
  • LEGN 7.0B
  • FRT 8.2B
  • IPO Year
  • LEGN 2020
  • FRT N/A
  • Fundamental
  • Price
  • LEGN $27.80
  • FRT $95.20
  • Analyst Decision
  • LEGN Strong Buy
  • FRT Buy
  • Analyst Count
  • LEGN 13
  • FRT 12
  • Target Price
  • LEGN $75.67
  • FRT $117.58
  • AVG Volume (30 Days)
  • LEGN 1.6M
  • FRT 737.8K
  • Earning Date
  • LEGN 05-13-2025
  • FRT 05-08-2025
  • Dividend Yield
  • LEGN N/A
  • FRT 4.62%
  • EPS Growth
  • LEGN N/A
  • FRT 23.89
  • EPS
  • LEGN N/A
  • FRT 3.47
  • Revenue
  • LEGN $728,303,000.00
  • FRT $1,223,588,000.00
  • Revenue This Year
  • LEGN $65.96
  • FRT $5.09
  • Revenue Next Year
  • LEGN $52.55
  • FRT $5.76
  • P/E Ratio
  • LEGN N/A
  • FRT $27.41
  • Revenue Growth
  • LEGN 112.46
  • FRT 6.05
  • 52 Week Low
  • LEGN $29.27
  • FRT $80.65
  • 52 Week High
  • LEGN $60.87
  • FRT $118.34
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 29.31
  • FRT 50.47
  • Support Level
  • LEGN $30.25
  • FRT $93.11
  • Resistance Level
  • LEGN $33.30
  • FRT $98.74
  • Average True Range (ATR)
  • LEGN 1.72
  • FRT 1.88
  • MACD
  • LEGN -0.41
  • FRT 0.35
  • Stochastic Oscillator
  • LEGN 3.14
  • FRT 49.86

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About FRT Federal Realty Investment Trust

Federal Realty Investment Trust is a shopping center-focused retail real estate investment trust that owns high-quality properties in eight of the largest metropolitan markets. Its portfolio includes an interest in 102 properties, which includes 26.8 million square feet of retail space and over 3,100 multifamily units. Federal's retail portfolio includes grocery-anchored centers, superregional centers, power centers, and mixed-use urban centers. Federal Realty has focused on owning assets in highly desirable areas with significant growth, and as a result, the average population density and average median household income are higher for its portfolio than for any other retail REIT.

Share on Social Networks: